Sponsor intelligence · OTHER
Clinical trials sponsored by
Liping Dou.
Real, source-linked trial activity for Liping Dou: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 26, 2026. Source-linked, daily-refreshed.
PHASE1 1PHASE2 1PHASE1/PHASE2 1
Newest Liping Dou trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractor | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 36d ago | CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After | Ph 2 | RECRUITING | ↗ |
| 36d ago | A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination | Ph 1/Ph 2 | ACTIVE_NOT_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Liping Dou (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.